fbpx Back to Top

Mantle Cell Lymphoma

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.

 

For current information, log in to FundFinder.

Assistance Amount

$8,300 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for mantle cell lymphoma.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Active Injection Kit D (dexamethasone sodium phosphate/pf)
  • Adriamycin (doxorubicin hcl)
  • Bendeka (bendamustine hcl)
  • Betamethasone Acetate-sod Phos (betamethasone acetate and sodium phos in sterile water/pf)
  • Betamethasone Sod Phos-acetate (betamethasone acetate/betamethasone sodium phosphate)
  • Bicnu (carmustine)
  • Bortezomib (bortezomib)
  • Calquence (acalabrutinib)
  • Carboplatin (carboplatin)
  • Cisplatin (cisplatin)
  • Cladribine (cladribine)
  • Cyclophosphamide (cyclophosphamide)
  • Cytarabine (cytarabine/pf)
  • Deltasone (prednisone)
  • Depo-medrol (methylprednisolone acetate)
  • Dexamethasone Intensol (dexamethasone)
  • Dexamethasone Sodium Phosphate (dexamethasone sodium phosphate)
  • Dexpak (dexamethasone)
  • Doubledex (dexamethasone sodium phosphate/pf)
  • Doxorubicin Hcl (doxorubicin hcl)
  • Etopophos (etoposide phosphate)
  • Etoposide (etoposide)
  • Fludarabine Phosphate (fludarabine phosphate)
  • Gemcitabine Hcl (gemcitabine hcl)
  • Gemzar (gemcitabine hcl)
  • Ifex (ifosfamide)
  • Ifosfamide (ifosfamide)
  • Ifosfamide-mesna (ifosfamide/mesna)
  • Imbruvica (ibrutinib)
  • Leucovorin Calcium (leucovorin calcium)
  • Matulane (procarbazine hcl)
  • Medrol (methylprednisolone)
  • Mesna (mesna)
  • Mesnex (mesna)
  • Methotrexate (methotrexate sodium)
  • Methylprednisolone (methylprednisolone)
  • Methylprednisolone Acetate (methylprednisolone acetate)
  • Methylprednisolone Sodium Succ (methylprednisolone sodium succinate)
  • Mitoxantrone Hcl (mitoxantrone hcl)
  • Nipent (pentostatin)
  • Oxaliplatin (oxaliplatin)
  • Prednisone (prednisone)
  • Rayos (prednisone)
  • Revlimid (lenalidomide)
  • Rituxan (rituximab)
  • Rituxan Hycela (rituximab/hyaluronidase, human recombinant)
  • Toposar (etoposide)
  • Treanda (bendamustine hcl)
  • Triamcinolone Acetonide (triamcinolone acetonide)
  • Triamcinolone Diacetate (triamcinolone diacetate in 0.9 % sodium chloride)
  • Velcade (bortezomib)
  • Venclexta (venetoclax)
  • Venclexta Starting Pack (venetoclax)
  • Vincasar Pfs (vincristine sulfate)
  • Vincristine Sulfate (vincristine sulfate)

Diagnosis Codes:

ICD-10: C83.10, C83.11, C83.12, C83.13, C83.14, C83.15, C83.16, C83.17, C83.18, C83.19

 

About the Disease:

Mantle cell lymphoma (MCL) is a type of cancer that usually begins with the enlargement of the lymph nodes and can spread to other tissues. MCL affects the lymphatic system. 

 

Source: National Institutes of Health

 

Related Organizations: